Navigation Links
ConvaTec and HemCon Announce Co-Promotion Agreement
Date:4/15/2009

l commercial operations in Ireland; England; Germany and the Czech Republic. For more information, please visit www.hemcon.com.

References

  1. Robinson BJ. The use of a Hydrofiber(R) dressing in wound management. J Wound Care 2000;9(1):32-34.
  2. Armstrong SH, Brown DA, Hill E, Ruckley CV. A randomized trial of a new Hydrofiber(R) dressing, AQUACEL(R), and an alginate in the treatment of exuding leg ulcers. Presented at: 5th European Conference on Advances in Wound Management; Harrogate, UK: November 1995.
  3. Caruso DM, Foster KN, Blome-Eberwein SA et al. Randomized clinical study of Hydrofiber(R) dressing with silver or silver sulfadiazine in the management of partial-thickness burns. J Burn Care Res. 2006; 27(3):298-309.
  4. Kogan L, Moldavsky M, Szvalb S, Govrin-Yehudain J. Comparative study of Aquacel(R) and Silverol(R) treatment in burns. Ann Burns Fire Disasters. 2004; 17(4):201-207.
  5. Jones SA, Bowler PG, Walker M, Parsons D. Controlling wound bioburden with a novel silver-containing Hydrofiber(R) dressing. Wound Repair Regen. 2004;12(3):288-294.

AQUACEL, Hydrofiber, and FlexiSeal are registered trademarks of ConvaTec Inc.

Our world is what we make of it is a trademark of ConvaTec Inc.

(C)2009 ConvaTec Inc.

AP-007329-US

    Contacts

    Punnie Donohue
    ConvaTec
    908-904-2151
    punnie.donohue@convatec.com

    Nicole Elovitz
    HemCon Medical Technologies, Inc.
    971-223-4918
    nicolee@hemcon.com


'/>"/>
SOURCE ConvaTec
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. ConvaTec Launches SUR-FIT Natura(R) Low-Pressure Adaptor
2. ConvaTec Names Presidents of Wound Therapeutics and Ostomy Care Business Units
3. ConvaTec Launches New Lifestyle Magazine for People With an Ostomy
4. ConvaTec Announces Expanded Indications for AQUACEL(R) and AQUACEL(R) Ag Dressings in Management of Surgical Wounds
5. ConvaTec Announces Divestiture of Unomedical Wound Care and Ophthalmics Business
6. ConvaTec Names Paul Moraviec President, Continence and Critical Care Business Unit and ConvaTec EMEA Region
7. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
8. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
9. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
10. HEI, Inc. Announces Sale of RFID Division Assets
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Dynatronics Receives 180-Day NASDAQ Extension 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 2Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 3Relapse of Infections is the Most Challenging Aspect of Treating Clostridium Difficile Infections in the Hospital Setting 55979 1Relapse of Infections is the Most Challenging Aspect of Treating Clostridium Difficile Infections in the Hospital Setting 55979 2Relapse of Infections is the Most Challenging Aspect of Treating Clostridium Difficile Infections in the Hospital Setting 55979 3Jiangbo Pharmaceuticals to Present at Rodman 26 Renshaw Annual Global Investment Conference 13788 1Jiangbo Pharmaceuticals to Present at Rodman 26 Renshaw Annual Global Investment Conference 13788 2Jiangbo Pharmaceuticals to Present at Rodman 26 Renshaw Annual Global Investment Conference 13788 3September 2009 is Atrial Fibrillation Month 55975 1September 2009 is Atrial Fibrillation Month 55975 2